PMID: 9643310Jun 27, 1998Paper

Interleukin-2 and systemic lupus erythematosus--fifteen years later

Lupus
J C Crispin, J Alcocer-Varela

Abstract

Systemic lupus erythematosus (SLE) is a highly heterogeneous disorder in which multiple immunologic abnormalities have been described. In this review, we thoroughly analyse the impaired T cell production of, and response to, interleukin-2 (IL-2) characteristic of patients with SLE. Since it was first reported, several articles have provided us with enlightening, but somewhat confusing, data that reveal the complexity of the subject. The IL-2 production by T cells is part of a complex network in which a discrete alteration is capable of disrupting the whole system. On the other hand, regulatory mechanisms exist that, in an attempt to compensate the primary alteration, provoke secondary defects. Evidence indicates that this defect is not intrinsic, but rather, results from multiple microenvironmental influences that act on the T cell and modify its activation state and its cytokine production. Abnormalities in co-stimulatory mechanisms and in cytokines that may be related to the IL-2 production deficiency, have been described in patients with SLE. We also consider the information derived from murine SLE models, IL-2 knockout models and reports concerning the immune dysregulation present in patients with SLE.

References

Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·T SakaneI Green
Nov 1, 1992·European Journal of Immunology·J C Gutierrez-RamosC Martínez
Apr 1, 1992·Clinical Immunology and Immunopathology·M Linker-Israeli
Dec 1, 1991·Clinical Immunology and Immunopathology·G Kroemer, C Martínez
Jan 1, 1991·Advances in Immunology·G KroemerC Martínez
Mar 1, 1991·Clinical and Experimental Immunology·K TomizawaS Matsumoto
Aug 1, 1991·Clinical Immunology and Immunopathology·Y TadaY Niho
Oct 15, 1990·Annals of Internal Medicine·L A Rubin, D L Nelson
May 1, 1990·Clinical Immunology and Immunopathology·T HishikawaT Shirai
Nov 1, 1989·Journal of Clinical Immunology·S SierakowskiJ S Goodwin
Mar 1, 1989·Clinical Immunology and Immunopathology·M N ManoussakisH M Moutsopoulos
May 1, 1989·Clinical Immunology and Immunopathology·I SekigawaT Shirai
May 1, 1985·Ultrasound in Medicine & Biology·B LavandierJ Motin
Jun 1, 1988·Arthritis and Rheumatism·R E Wolf, W G Brelsford
Jan 1, 1988·Life Sciences·E J Kucharz, J S Goodwin
Dec 18, 1987·Science·B J BrandhuberD B McKay
May 1, 1986·The Journal of Experimental Medicine·D M KlinmanA D Steinberg
Jan 1, 1986·Australian Veterinary Journal·J G AllenM F D'Antuono
Oct 1, 1982·Scandinavian Journal of Immunology·J B Smith, N Talal
Jul 1, 1982·Arthritis and Rheumatism·N TalalD Wofsy
Apr 1, 1984·Clinical Immunology and Immunopathology·N MiyasakaN Talal
Jan 1, 1981·European Journal of Immunology·E C LattimeO Stutman
Jul 1, 1983·European Journal of Immunology·T J SantoroA D Steinberg
Dec 1, 1983·The Journal of Experimental Medicine·D A Cantrell, K A Smith
Nov 1, 1981·The Journal of Experimental Medicine·D WofsyN Talal
Jun 1, 1982·The Journal of Clinical Investigation·J Alcocer-Varela, D Alarcón-Segovia
Sep 1, 1993·Current Opinion in Rheumatology·C S Via, B S Handwerger
Mar 1, 1995·Clinical and Experimental Immunology·H BeckerK Federlin

❮ Previous
Next ❯

Citations

Mar 22, 2002·Nature Reviews. Immunology·John J O'SheaPeter Lipsky
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jens Y HumrichGabriela Riemekasten
Jun 24, 2004·The Tohoku Journal of Experimental Medicine·Young Moo LeeTadao Funato
May 25, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Thomas M HerndonGeorge C Tsokos
Jun 3, 2016·Zeitschrift für Rheumatologie·J Y Humrich, G Riemekasten
Oct 21, 2016·Expert Review of Clinical Immunology·Jens Y Humrich, Gabriela Riemekasten
Aug 21, 2001·Rheumatology·M AringerW B Graninger
Jun 27, 1998·Lupus·B R Lauwerys, F A Houssiau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.